We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
Discount
CPP Members! There will be a new Pfizer contract in place effective July 1, 2025 that offers CPP members an…
Motivate to Vaccinate – CPP members, join us on June 24 at 12PM ET (9AM PT) for a live webinar…
May is Hepatitis Awareness Month, and Dynavax is spearheading efforts to improve education about hepatitis B and the benefits of…
The COVID-19 pandemic reshaped public attitudes toward vaccines, highlighting their vital role in protecting individual and community health. With this…
The United States is witnessing a troubling rise in measles cases, with a significant outbreak in Texas reaching 90 confirmed…
The CDC published updated expanded recommendations from the Advisory Committee on Immunization Practices (ACIP) for pneumococcal conjugate vaccines (PCV) among…
There was quite a bit of discussion at the October ACIP meeting about the exciting advancements in preventing invasive pneumococcal…
CPP Members, please keep an eye out for your CPP semi-annual rebate that will be coming by mail this month!…
CPP members who participate in the Pfizer vaccine contract can now access a discount on Pfizer’s LUCIRA®, a 2-in-1 molecular…